Treating glaucoma in the age of MIGS and laser

Surgeons’ protocols continue to evolve as new options appear and gradually prove their value.

April 2021

COVID-19

The pandemic has impacted every practice differently, but the changes it’s wrought may last a long time.

Intraocular Lenses

Three unique, non-diffractive/non-multifocal IOLs that strive for a greater range of vision.

Refractive Surgery

Postop results and safety profiles are similar, but there are key differences between the procedures.

COVID-19

The truth may surprise you. Find out the ups and downs and future outlook.

Forum

Musings on life, ophthalmology and global pandemics.

Juxtapapillary Dropout & RNFL Thinning in Glaucoma
Find out what eyes with juxtapapillary microvasculature dropout revealed about glaucoma progression.
Early Experience with Brolucizumab Treatment of nAMD
See how brolucizumab intravitreous injection affected visual acuity, central subfield thickness and intraocular inflammation.
Infectious Keratitis After Boston Type 1 Keratoprosthesis Implantation
Learn what percentage of people developed infectious keratitis after KPro implantation, and which type of infectious keratitis was more common.
Imaging Biomarkers to Predict Responsive & Unresponsive Cases Treated with Standardized Anti-VEGF Regimen in nAMD
What factors were useful to predict a poor treatment response?
Industry News

A Closer Look: Emerging Medical Therapies for Presbyopia
This CME activity provides an overview of age-related loss of accommodation as well as several of the emerging topical therapies for presbyopia that are under investigation. Perspectives on selection of prospective patients as well as potential opportunities for practice growth are also discussed.
Don't Miss Neurotrophic Keratitis: New Approaches to Assess and Treat
A panel of experts discuss the importance of early detection of neurotrophic keratitis and the latest data on available treatment options in this CME activity.
Breaking New Ground: Reducing Treatment Burden in Neovascular AMD
This CME monograph, based on an expert roundtable discussion, will present challenging cases in nAMD along with the latest clinical trial data and perspectives on how the newest advances in nAMD treatment can be translated to the real world.

View More CME